Trials / Unknown
UnknownNCT00686387
Establishment of a Brain and Spinal Tumor Tissue Bank
Establishment of a Brain and Spinal Tumor Tissue Bank and Clinical Data Repository for Identifying Molecular Markers of Clinical Outcome
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (estimated)
- Sponsor
- Taipei Medical University WanFang Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to establish a Brain and Spinal Tumor Tissue/Specimen repository to serve as a resource for current and future scientific studies.
Detailed description
Glioblastoma multiforme (GBM) is the most common and lethal primary Brain and Spinal Tumor in adults. It is nearly uniformly fatal, with a median survival of approximately one year, despite modern treatment modalities. Efforts to understand why some patients live longer or shorter than the average may provide insights into the biology of these neoplasms. For years, researchers have tried to identify independent predictors that could help in treatment planning. With the recent interest in molecular biology and molecular genetics, tumor markers are now being examined as potential predictors. A marker that could predict tumor response to therapy, the likelihood of recurrence, and survival would thus be quite useful.
Conditions
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2008-05-29
- Last updated
- 2011-04-12
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00686387. Inclusion in this directory is not an endorsement.